Thank you

This live web event has ended. Thank you for attending.

Description

COVID-19 and Beyond:
the Role of Syndromic Testing in a
changing Respiratory Landscape

Why should you register now for this webinar?
Participate in an expert-led discussion on how the BioFire^® Respiratory 2.1 (RP2.1)
Panel has helped address the challenges of running a clinical laboratory during the
COVID-19 pandemic.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenters: Gregory J. Berry, PhD, D(ABMM)

What will this webinar empower you to do?
Better understand the potential role of syndromic testing as respiratory pathogen
epidemiology evolves in the era of COVID-19.
Learn how implementation of a rapid and sensitive respiratory panel can help
guide patient management decisions for patients with suspected respiratory tract infections.
Review performance data from the De Novo authorized BioFire RP2.1 Panel
clinical study
Ask questions of our distinguished presenters

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from BioFire.